Cargando…

Myocardial fibrosis detected with gadolinium delayed enhancement in cardiac magnetic resonance imaging is related with arterioventricular coupling alterations in patients with acute myocarditis

Detalles Bibliográficos
Autores principales:	Chrysohoou, Christina, Henry, Travis, Stillman, Arthur, Lerakis, Stamatios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328484/ http://dx.doi.org/10.1186/1532-429X-17-S1-P345

Ejemplares similares

The role of cardiovascular magnetic resonance in stratifying paravalvular leak severity after transcatheter aortic valve replacement: an observational outcome study
por: Hartlage, Gregory R, et al.
Publicado: (2014)

Cardiac magnetic resonance imaging: the future is bright
por: Seetharam, Karthik, et al.
Publicado: (2019)

Myocardial Edema without Fibrosis by Magnetic Resonance T2 Mapping in Acute Chagas’ Myocarditis
por: de Sousa, Andréa Silvestre, et al.
Publicado: (2017)

Late gadolinium enhancement characteristics in giant cell myocarditis
por: Yang, Shujuan, et al.
Publicado: (2021)

Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain
por: Lerakis, Stamatios, et al.
Publicado: (2009)

Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy
por: Latus, Heiner, et al.
Publicado: (2015)

Quantitative Assessment of Late Gadolinium Enhancement and Edema at Cardiac Magnetic Resonance in Low-Risk Myocarditis Patients
por: Monti, Caterina Beatrice, et al.
Publicado: (2022)

Detection and evaluation of myocardial fibrosis in Eisenmenger syndrome using cardiovascular magnetic resonance late gadolinium enhancement and T1 mapping
por: Gong, Chao, et al.
Publicado: (2022)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate
por: Gallegos, Cesia, et al.
Publicado: (2019)

Gadolinium changes detected on cardiovascular magnetic resonance imaging following COVID-19 vaccine-related myocarditis in adolescents
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Adenosine magnetic resonance imaging versus dobutamine stress echocardiography in patients with low probability for coronary artery disease
por: Lerakis, Stamatios, et al.
Publicado: (2009)

Evaluation of myocardial fibrosis by post gadolinium T1 measurement in patients with pulmonary hypertension
por: Kallianos, Kimberly, et al.
Publicado: (2015)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
por: Gräni, Christoph, et al.
Publicado: (2019)

Comparison of 3D and 2D late gadolinium enhancement magnetic resonance imaging in patients with acute and chronic myocarditis
por: Polacin, M., et al.
Publicado: (2020)

Delayed gadolinium-enhanced magnetic resonance imaging of hip joint cartilage: pearls and pitfalls
por: Bittersohl, Bernd, et al.
Publicado: (2011)

Comparison of the amount of affected myocardium quantified by late gadolinium enhancement and the degree of myocardial necrosis measured by cardiac troponin T in patients with myocarditis
por: Andre, Florian, et al.
Publicado: (2013)

Submillimeter diffusion tensor imaging and late gadolinium enhancement cardiovascular magnetic resonance of chronic myocardial infarction
por: Pashakhanloo, Farhad, et al.
Publicado: (2017)

A Case of Delayed Onset Nephrogenic Systemic Fibrosis After Gadolinium Based Contrast Injection
por: Do, Jong Geol, et al.
Publicado: (2012)

Association between ECG parameters and late gadolinium enhancement along the course of myocarditis
por: Károlyi, Mihály, et al.
Publicado: (2023)

User-dependence of myocardial infarct identification using semi-automated thresholding techniques: implications for CRT response predictions based on scar burden
por: Suever, Jonathan, et al.
Publicado: (2011)

Cardiovascular Magnetic Resonance in Myocarditis
por: Polte, Christian L., et al.
Publicado: (2022)

Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis
por: Stensaeth, Knut Haakon, et al.
Publicado: (2011)

Assessment of myocardial strain in patients with myocarditis by cardiac magnetic resonance imaging
por: Andre, Florian, et al.
Publicado: (2014)

Reproducibility of T2 mapping and its comparison with Delayed Gadolinium Enhanced Magnetic Resonance Imaging (dGEMRIC) scanning in the hip
por: Fernquest, Scott James, et al.
Publicado: (2016)

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance
por: Kirk, Paul, et al.
Publicado: (2011)

Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis
por: Keller, Sarah, et al.
Publicado: (2018)

Association of QRS-T angle and Late Gadolinium Enhancement in patients with a Clinical Suspicion of Myocarditis
por: Jensen, C.J., et al.
Publicado: (2021)

Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality
por: Cardona, Andrea, et al.
Publicado: (2019)

Gray blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of myocardial scar
por: Fahmy, Ahmed S., et al.
Publicado: (2018)

Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement
por: Erley, Jennifer, et al.
Publicado: (2019)

Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy
por: Schelbert, Erik B., et al.
Publicado: (2017)

MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study
por: Bandettini, W Patricia, et al.
Publicado: (2012)

Prognostic significance of regional edema and quantitative assessment of late gadolinium enhancement in patients with acute myocarditis
por: Vermes, Emmanuelle, et al.
Publicado: (2011)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

A case of coronavirus disease 2019 vaccine‐related myocarditis with late gadolinium enhancement on cardiac magnetic resonance imaging persisting over acute phase
por: Konno, Ai, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of Delayed Gadolinium Enhanced Magnetic Resonance Imaging (dGEMRIC) in Early Osteoarthritis of the Hip
por: Palmer, Antony, et al.
Publicado: (2016)

Extent of late gadolinium enhancement in patients with hypertrophic cardiomyopathy in correlation with serum MMP9 as an indicator of myocardial fibrosis
por: Avanesov, Maxim, et al.
Publicado: (2014)

Assessment of myocardial fibrosis by late gadolinium enhancement imaging and biomarkers of collagen metabolism in chronic rheumatic mitral regurgitation
por: Ruchika, Meel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jf1nqinknrhi38psns8355md0d